CLINICAL_TRIALS
trial_result
· 2022-03-17
Clinical Trial Update: Surviving PEA in Roanoke (SPEAR) Study [Phase 2, Phase 3]
Summary
Phase 2/3 clinical trial update for the SPEAR study investigating outcomes in cardiac arrest with pulseless electrical activity; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Carol Bernier | Conditions: Cardiac Arrest, Pulseless Electrical Activity | Phase 2, Phase 3 | Status: RECRUITING